Browsing Topic

USFDA

3 posts
A toilet in an abandoned spot

Immuron progresses development of traveller’s diarrhea drug Travelan

Immuron Ltd has presented a Clinical Study Report to the US Food and Drug Administration following…
Nitroglycerin chemical structure

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%,…
Mesoblast (ASX:MSB) - CEO & Managing Director, Silviu Itescu

Cashed up & ready to go: Mesoblast forges funding deal with top shareholder

Mesoblast (ASX:MSB) is trading up more than 1.75% after striking a funding deal with its largest…